National Institute of Health Researcher Leaving Due to Stricter Ethical Guidelines
Almost 40% of NIH tenure and tenure-track scientists have begun or have considered efforts to seek new employment because of new agency ethics rules "that have curtailed their opportunity to earn outside income," according to an internal survey, AP/USA Today reports. NIH implemented the rules last year after a review found that "dozens of scientists had run afoul of existing restrictions on private consulting deals that had enriched them with money from drug and biotechnology companies," AP/USA Today reports (Beamish, AP/USA Today, 10/28). Under the rules, the top 200 NIH officials must maintain holdings at or less than $15,000 in individual pharmaceutical and biotechnology companies. They also must limit their investments in health care sector funds at or less than $50,000. Lower-level NIH employees must inform their supervisors about potential conflicts of interest in their investments but do not have to file disclosures. In addition, NIH employees cannot accept consulting fees from pharmaceutical, biotech or medical device companies; health care providers; health insurers; or research institutions sponsored by the agency (Kaiser Daily Health Policy Report, 8/26/05).
Comments